HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Yamamoto Selected Research

SM 20550

1/2002Effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemic preconditioning in rabbits.
6/2001Inhibitory effect of SM-20550, an Na+/H+ exchange inhibitor, on accumulation of leukocytes in ischemia and reperfusion.
1/2001The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts.
9/2000Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits.
6/2000SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Yamamoto Research Topics

Disease

56Neoplasms (Cancer)
11/2016 - 01/2000
14Infections
12/2018 - 05/2000
13Neoplasm Metastasis (Metastasis)
08/2013 - 01/2000
13Hepatocellular Carcinoma (Hepatoma)
12/2006 - 09/2000
12Carcinoma (Carcinomatosis)
01/2008 - 01/2000
11Lung Neoplasms (Lung Cancer)
11/2013 - 11/2000
10Ischemia
04/2008 - 02/2000
9Body Weight (Weight, Body)
03/2016 - 01/2000
9Pain (Aches)
03/2012 - 03/2001
8Adenocarcinoma
09/2009 - 08/2000
8Breast Neoplasms (Breast Cancer)
01/2006 - 01/2000
8Carcinogenesis
12/2001 - 01/2000
8Hyperplasia
11/2001 - 01/2000
7Inflammation (Inflammations)
01/2017 - 06/2000
7Pathologic Constriction (Stenosis)
04/2012 - 02/2000
7Hemorrhage
04/2012 - 09/2000
7Reperfusion Injury
12/2011 - 06/2000
7Portal Hypertension
12/2009 - 05/2001
6Necrosis
09/2014 - 03/2000
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013 - 01/2001
6Ulcerative Colitis
03/2012 - 07/2000
6Liver Failure
12/2009 - 09/2001
6Stomach Neoplasms (Stomach Cancer)
09/2009 - 07/2000
6Rheumatoid Arthritis
02/2004 - 05/2000
6Hereditary Corneal Dystrophies
08/2001 - 01/2000
5Atrophy
12/2009 - 08/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2005 - 01/2000
5Osteoarthritis
02/2003 - 01/2001
4Stroke (Strokes)
03/2017 - 02/2001
4Type 2 Diabetes Mellitus (MODY)
03/2017 - 02/2000
4Fibrosis (Cirrhosis)
01/2017 - 05/2001
4Colorectal Neoplasms (Colorectal Cancer)
04/2015 - 09/2001
4Autoimmune Hepatitis
03/2012 - 10/2008
4Thrombosis (Thrombus)
03/2012 - 12/2002
4Liver Cirrhosis (Hepatic Cirrhosis)
10/2008 - 05/2001
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2002 - 06/2000
4Infarction (Infarctions)
01/2002 - 09/2000
4Prostatic Neoplasms (Prostate Cancer)
11/2001 - 07/2001
3Hypersensitivity (Allergy)
01/2017 - 08/2000
3Obesity
03/2016 - 04/2005
3Chronic Kidney Failure (Chronic Renal Failure)
09/2014 - 05/2001
3Death (Near-Death Experience)
05/2014 - 03/2010
3Liver Diseases (Liver Disease)
02/2014 - 11/2001
3Retinal Perforations
09/2012 - 03/2000
3Varicose Veins (Varicose Vein)
04/2012 - 12/2001
3Fistula
01/2012 - 10/2008
3Acute Liver Failure (Fulminant Hepatic Failure)
04/2010 - 10/2004
3Lymphatic Metastasis
09/2009 - 01/2000
3Hepatitis
10/2008 - 04/2000
3Leukopenia
01/2008 - 01/2001

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2000
10Messenger RNA (mRNA)IBA
03/2016 - 02/2000
8CytokinesIBA
11/2014 - 03/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2016 - 01/2000
6Tacrolimus (Prograf)FDA LinkGeneric
02/2011 - 01/2001
5Interleukin-6 (Interleukin 6)IBA
02/2017 - 03/2000
5Glucose (Dextrose)FDA LinkGeneric
03/2016 - 02/2000
5DNA (Deoxyribonucleic Acid)IBA
10/2012 - 01/2000
5Indicators and Reagents (Reagents)IBA
01/2009 - 07/2000
5Retinaldehyde (Retinal)IBA
01/2009 - 02/2001
5SM 20550IBA
01/2002 - 06/2000
4Immunoglobulin E (IgE)IBA
01/2017 - 03/2000
4LeptinIBA
03/2016 - 02/2000
4C-Reactive ProteinIBA
01/2015 - 10/2000
4EnzymesIBA
10/2012 - 01/2000
4Biomarkers (Surrogate Marker)IBA
03/2011 - 04/2001
4LipidsIBA
06/2010 - 02/2001
4CholesterolIBA
03/2004 - 07/2000
4methanesulfonic acid (methanesulfonate)IBA
01/2002 - 06/2000
3Ganciclovir (Cytovene)FDA LinkGeneric
12/2018 - 06/2000
3Interleukin-8 (Interleukin 8)IBA
02/2017 - 07/2000
3dicarboxydine (DCD)IBA
05/2014 - 03/2010
3Anesthetics (Anesthetic Agents)IBA
01/2014 - 02/2000
3VimentinIBA
11/2011 - 11/2000
3Cisplatin (Platino)FDA LinkGeneric
09/2009 - 01/2001
3LuciferasesIBA
12/2006 - 07/2001
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2006 - 12/2001
3AcidsIBA
11/2005 - 10/2000
3Phenobarbital (Luminal)FDA Link
08/2002 - 02/2000

Therapy/Procedure

37Therapeutics
12/2018 - 01/2000
31Liver Transplantation
04/2012 - 09/2001
18Drug Therapy (Chemotherapy)
06/2012 - 06/2000
12Lymph Node Excision (Lymph Node Dissection)
09/2009 - 08/2000
8Radiotherapy
01/2008 - 04/2000
7Stents
01/2012 - 02/2000
6Operative Surgical Procedures
10/2008 - 04/2000
5Hepatectomy
04/2012 - 08/2000
4Transplantation
05/2014 - 01/2004
4Vitrectomy
09/2012 - 01/2000
4Decompression
01/2009 - 05/2001
4Splenectomy
10/2008 - 01/2001
4Segmental Mastectomy (Lumpectomy)
10/2007 - 07/2000
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2001 - 04/2000
3Surgical Portasystemic Shunt (Portosystemic Shunt)
04/2017 - 12/2009
3Renal Dialysis (Hemodialysis)
05/2014 - 02/2001
3Conservative Treatment
03/2012 - 12/2001
3Ligation
12/2009 - 05/2001
3Cardiopulmonary Bypass (Heart-Lung Bypass)
08/2005 - 04/2001
3Colectomy
10/2004 - 09/2001
3Osteotomy
02/2003 - 02/2001